Longitudinal microperimetry evaluation after intravitreal ocriplasmin injection for vitreomacular traction

Andrea Cacciamani, Aldo Gelso, Joseph M. Simonett, Guido Ripandelli, Marco Pileri, Mario Stirpe, Fabio Scarinci

Research output: Contribution to journalArticlepeer-review


Purpose: To determine whether improvements in microperimetry testing are associated with anatomic resolution after ocriplasmin treatment in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction and relatively preserved baseline best-corrected visual acuity (BCVA). Methods: Patients with vitreomacular traction received a single 125-g intravitreal ocriplasmin injection and were followed longitudinally for 6 months with optical coherence tomography, BCVA testing, and microperimetry. Visual function changes were compared between eyes with and without VMA resolution on optical coherence tomography. Results: Eleven of 16 eyes (68.8%) achieved VMA resolution after treatment. Mean baseline BCVA was relatively good (79 ± 3 Early Treatment Diabetic Retinopathy Study letters; 20/52); no patients had a ≥2-line improvement in BCVA over the 6-month follow-up period. In the group with VMA resolution, mean retinal sensitivity significantly increased in the central 4° (15.2 ± 1.9 dB vs. 18.9 ± 0.7 dB, P < 0.001) when comparing baseline and final follow-up microperimetry testing. No change in mean retinal sensitivity was found in the group without VMA resolution. Conclusion: Microperimetry demonstrates a significant gain in retinal sensitivity, particularly in the central 4° area, in eyes with anatomic resolution after treatment of vitreomacular traction with intravitreal ocriplasmin injection, even when no significant gain in BCVA is seen.

Original languageEnglish
Pages (from-to)1832-1838
Number of pages7
Issue number10
Publication statusPublished - Oct 1 2017


  • microperimetry
  • ocriplasmin
  • vitreomacular traction

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Longitudinal microperimetry evaluation after intravitreal ocriplasmin injection for vitreomacular traction'. Together they form a unique fingerprint.

Cite this